Abel Jarell is a Dermatology physician affiliated with Portsmouth Regional Hospital. OpenAlex indexes 67 publications with 1,292 citations (h-index 17).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingIndustry payments
319 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
319 companies with payments on record in CMS Open Payments (2021 onward), matched to this physician's NPI. The itemized breakdown by company, amount and year is part of the full profile. Why? →
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Dermatology
32.7%Corticosteroid24.4%Triamcinolone Acetonide81%Triamcinolone acetonide19%Part D + Part B≥85 patientsPolyene Antifungal5%Nystatin100%Part D≥12 patients+ 1 more class in this area
Anti-infectives
22.4%Tetracycline-class Drug13.7%Doxycycline Hyclate85%Doxycycline Ir-Dr15%Part D<11 patientsAzole Antifungal6.5%Ketoconazole100%Part D≥31 patients+ 1 more class in this area
Sensory organs
21.4%Corticosteroid21.4%Clobetasol Propionate68%Betamethasone Dipropionate20%Desonide12%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- The 31-Gene Expression Profile Test Identifies Patients with AJCC T1a (&lt;0.8mm) Cutaneous Melanoma at Increased Risk of 5-year Melanoma-Specific Mortality
SKIN The Journal of Cutaneous Medicine
2026 - Safety and Adverse Events of Special Interest in 825 Adults With Atopic Dermatitis Receiving Up to 12 Months of Tralokinumab Treatment in a Real-World Setting
SKIN The Journal of Cutaneous Medicine
2026 - 62823 Optimization of deuruxolitinib dosing in adult patients with alopecia areata: Results from a randomized, parallel-group, multicenter, Phase 2 trial
Journal of the American Academy of Dermatology
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Hywel C Williams
University of Nottingham
Mohsen Afarideh, MD, MPH
Mayo Clinic
Brigitte Dréno
Centre National de la Recherche Scientifique
Giovanni Damiani
University of Milan
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”